Borg L - Search Results

1

Altered levels of basal cortisol in healthy subjects with a 118G allele in exon 1 of the Mu opioid receptor gene.

Bart G, LaForge KS, Borg L, Lilly C, Ho A, Kreek MJ. Bart G, et al. Among authors: borg l. Neuropsychopharmacology. 2006 Oct;31(10):2313-7. doi: 10.1038/sj.npp.1301128. Epub 2006 Jun 21. Neuropsychopharmacology. 2006. PMID: 16794569 Clinical Trial.

2

Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?

Bart G, Schluger JH, Borg L, Ho A, Bidlack JM, Kreek MJ. Bart G, et al. Among authors: borg l. Neuropsychopharmacology. 2005 Dec;30(12):2254-62. doi: 10.1038/sj.npp.1300811. Neuropsychopharmacology. 2005. PMID: 15988468

3

Altered HPA axis responsivity to metyrapone testing in methadone maintained former heroin addicts with ongoing cocaine addiction.

Schluger JH, Borg L, Ho A, Kreek MJ. Schluger JH, et al. Among authors: borg l. Neuropsychopharmacology. 2001 May;24(5):568-75. doi: 10.1016/S0893-133X(00)00222-0. Neuropsychopharmacology. 2001. PMID: 11282257

4

Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism.

King AC, Schluger J, Gunduz M, Borg L, Perret G, Ho A, Kreek MJ. King AC, et al. Among authors: borg l. Neuropsychopharmacology. 2002 Jun;26(6):778-88. doi: 10.1016/S0893-133X(01)00416-X. Neuropsychopharmacology. 2002. PMID: 12007748

5

The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.

Borg L, Ho A, Wells A, Joseph H, Appel P, Moody D, Kreek MJ. Borg L, et al. J Addict Dis. 2002;21(3):13-22. doi: 10.1300/J069v21n03_02. J Addict Dis. 2002. PMID: 12094997

6

Suppressed prolactin response to dynorphin A1-13 in methadone-maintained versus control subjects.

Bart G, Borg L, Schluger JH, Green M, Ho A, Kreek MJ. Bart G, et al. Among authors: borg l. J Pharmacol Exp Ther. 2003 Aug;306(2):581-7. doi: 10.1124/jpet.103.050682. Epub 2003 May 2. J Pharmacol Exp Ther. 2003. PMID: 12730354 Clinical Trial.

7

Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism.

Schluger JH, Ho A, Borg L, Porter M, Maniar S, Gunduz M, Perret G, King A, Kreek MJ. Schluger JH, et al. Among authors: borg l. Alcohol Clin Exp Res. 1998 Oct;22(7):1430-6. doi: 10.1111/j.1530-0277.1998.tb03931.x. Alcohol Clin Exp Res. 1998. PMID: 9802524

8

Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.

Kreek MJ, Schluger J, Borg L, Gunduz M, Ho A. Kreek MJ, et al. Among authors: borg l. J Pharmacol Exp Ther. 1999 Jan;288(1):260-9. J Pharmacol Exp Ther. 1999. PMID: 9862779 Clinical Trial.

9

Acute subjective effects of dynorphin A(1-13) infusion in normal healthy subjects.

King AC, Ho A, Schluger J, Borg L, Kreek MJ. King AC, et al. Among authors: borg l. Drug Alcohol Depend. 1999 Mar 1;54(1):87-90. doi: 10.1016/s0376-8716(98)00150-1. Drug Alcohol Depend. 1999. PMID: 10101621 Clinical Trial.

10

Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment.

Piccolo P, Borg L, Lin A, Melia D, Ho A, Kreek MJ. Piccolo P, et al. Among authors: borg l. J Addict Dis. 2002;21(4):55-66. doi: 10.1300/J069v21n04_06. J Addict Dis. 2002. PMID: 12296502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters